交叉上市是改善盈利质量的灵丹妙药吗?中国H股和B股公司的案例

Is cross-listing a panacea for improving earnings quality? The case of H- and B-share firms in China

International Review of Financial Analysis · 2022
被引 12
ABS 3
交叉上市盈利质量公司治理中国资本市场